Shanghai, China

Chuanyin Li

This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chuanyin Li. Retrieved from https://idiyas.com/inventor/chuanyin-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Chuanyin Li

Introduction

Chuanyin Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of autism. His work is characterized by a focus on innovative uses of biological compounds.

Latest Patents

Chuanyin Li holds a patent for the "Use of ALDH1A and agonist, catalyst and inhibitor thereof." This patent discloses the use of ALDH1A or an agonist thereof, or a catalysate thereof in the preparation of a pharmaceutical composition or formulation aimed at treating and preventing autism. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Li is affiliated with the Chinese Academy of Sciences, where he conducts research and develops innovative solutions in the pharmaceutical sector. His work has garnered attention for its potential impact on autism treatment, highlighting his role as a key figure in this important area of research.

Collaborations

Some of his notable coworkers include Xiaobo Gao and Xingxing Xu. Their collaborative efforts contribute to the advancement of research and innovation within their field.

Conclusion

Chuanyin Li's contributions to the field of pharmaceuticals, particularly in autism treatment, underscore his importance as an inventor. His innovative work continues to pave the way for future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…